XENE

Xenon Pharmaceuticals Inc

May 15 • 04:00PM ET

54.39

-1.61 -2.88 %

Healthcare • Biotechnology • Canada • Mid • NASD

Peers: AXSM BHVN ALKS ACAD NBIX

| Held by: IWM IWO IBB VTWO SPDW SBIO VTWG VT FESM NUSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.70	Insider Own	2.88%	Shs Outstand	96.62M	Perf Week	-3.63%
Market Cap	5.26B	Forward P/E	-	EPS next Y	-4.93	Insider Trans	-11.51%	Shs Float	93.88M	Perf Month	-6.91%
Enterprise Value	4.17B	PEG	-	EPS next Q	-1.15	Inst Own	89.44%	Short Float	4.42%	Perf Quarter	31.12%
Income	-383.17M	P/S	-	EPS this Y	-9.61%	Inst Trans	0.26%	Short Ratio	2.94	Perf Half Y	37.07%
Sales	0.00M	P/B	3.93	EPS next Y	-3.23%	ROA	-35.98%	Short Interest	4.15M	Perf YTD	21.35%
Book/sh	13.85	P/C	4.80	EPS next 5Y	10.72%	ROE	-37.53%	52W High	63.95 -14.95%	Perf Year	83.94%
Cash/sh	11.33	P/FCF	-	EPS past 3/5Y	-28.36% -40.02%	ROIC	-28.51%	52W Low	28.19 92.94%	Perf 3Y	30.31%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-7.36% -25.26%	Gross Margin	-	Volatility	2.87% 3.37%	Perf 5Y	213.67%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-46.29%	Oper. Margin	-	ATR (14)	1.91	Perf 10Y	731.65%
Dividend Ex-Date	-	Quick Ratio	27.79	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	43.24	Recom	1.05
Dividend Gr. 3/5Y	- -	Current Ratio	27.79	EPS Q/Q	-41.69%	SMA20	-2.93%	Beta	0.64	Target Price	80.46
Payout	-	Debt/Eq	0.01	Sales Q/Q	-100.00%	SMA50	-3.49%	Rel Volume	0.43	Prev Close	56.00
Employees	370	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	22.17%	Avg Volume	1.41M	Price	54.39
IPO	Nov 05, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.81% -100.00%	Trades		Volume	610,216	Change	-2.88%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)